Gene Therapy in CNS Disorder - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2754353
- Published On: Oct, 2023
- Category : Healthcare & Pharma
- Pages : 138
-
According to Research, the global market for Gene Therapy in CNS Disorder should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Gene Therapy in CNS Disorder market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Gene Therapy in CNS Disorder market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Alzheimer's Disease grew percent to account for percent of the total market sales, and Huntington's Disease grew percent.
Gene therapy entails the specific transfer of genetic information into affected cells and tissues in order to restore function in diseased areas.
This report studies and analyses global Gene Therapy in CNS Disorder status and future trends, to help determine the Gene Therapy in CNS Disorder market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Gene Therapy in CNS Disorder, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Gene Therapy in CNS Disorder market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Gene Therapy in CNS Disorder by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Gene Therapy in CNS Disorder by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Gene Therapy in CNS Disorder key consuming regions, consumption value and demand structure
(5) Gene Therapy in CNS Disorder industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Voyager Therapeutics
Spark Therapeutics
Novartis AG
Bluebird Bio Inc.
Biogen
Market segment by Type, covers
Viral Gene Therapy
Non-viral Gene Therapy
Market segment by Application, can be divided into
Alzheimer's Disease
Huntington's Disease
Parkinson's Disease
Batten Disease
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Gene Therapy in CNS Disorder product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Gene Therapy in CNS Disorder market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Gene Therapy in CNS Disorder market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Gene Therapy in CNS Disorder industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Gene Therapy in CNS Disorder Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Gene Therapy in CNS Disorder Definition
1.2 Global Gene Therapy in CNS Disorder Market Size and Forecast
1.3 China Gene Therapy in CNS Disorder Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Gene Therapy in CNS Disorder Market Size: China VS Global Growth Rate, 2018-2029
1.6 Gene Therapy in CNS Disorder Market Dynamics
1.6.1 Gene Therapy in CNS Disorder Market Drivers
1.6.2 Gene Therapy in CNS Disorder Market Restraints
1.6.3 Gene Therapy in CNS Disorder Industry Trends
1.6.4 Gene Therapy in CNS Disorder Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Gene Therapy in CNS Disorder, Global Market Share by Company, 2018-2023
2.2 Global Gene Therapy in CNS Disorder Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Gene Therapy in CNS Disorder Concentration Ratio
2.4 Global Gene Therapy in CNS Disorder Mergers & Acquisitions, Expansion Plans
2.5 Global Gene Therapy in CNS Disorder Major Companies Product Type
2.6 Head Office and Gene Therapy in CNS Disorder Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Gene Therapy in CNS Disorder, China Market Share by Company, 2018-2023
3.2 China Gene Therapy in CNS Disorder Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Gene Therapy in CNS Disorder Industry Chain
4.2 Gene Therapy in CNS Disorder Upstream Analysis
4.2.1 Gene Therapy in CNS Disorder Core Raw Materials
4.2.2 Main Manufacturers of Gene Therapy in CNS Disorder Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Gene Therapy in CNS Disorder Production Mode
4.6 Gene Therapy in CNS Disorder Procurement Model
4.7 Gene Therapy in CNS Disorder Industry Sales Model and Sales Channels
4.7.1 Gene Therapy in CNS Disorder Sales Model
4.7.2 Gene Therapy in CNS Disorder Typical Distributors
5 Sights by Type5.1 Gene Therapy in CNS Disorder Classification
5.1.1 Viral Gene Therapy
5.1.2 Non-viral Gene Therapy5.2 By Type, Global Gene Therapy in CNS Disorder Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Gene Therapy in CNS Disorder Consumption Value, 2018-2029
6 Sights by Application6.1 Gene Therapy in CNS Disorder Segment by Application
6.1.1 Alzheimer's Disease
6.1.2 Huntington's Disease
6.1.3 Parkinson's Disease
6.1.4 Batten Disease6.2 By Application, Global Gene Therapy in CNS Disorder Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Gene Therapy in CNS Disorder Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Gene Therapy in CNS Disorder Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Gene Therapy in CNS Disorder Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Gene Therapy in CNS Disorder & Forecasts, 2018-2029
7.3.2 By Country, North America Gene Therapy in CNS Disorder Market Size Market Share7.4 Europe
7.4.1 Europe Gene Therapy in CNS Disorder Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Gene Therapy in CNS Disorder Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Gene Therapy in CNS Disorder Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Gene Therapy in CNS Disorder Market Size Market Share7.6 South America
7.6.1 South America Gene Therapy in CNS Disorder Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Gene Therapy in CNS Disorder Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Gene Therapy in CNS Disorder Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Gene Therapy in CNS Disorder Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Gene Therapy in CNS Disorder Market Size, 2018-2029
8.3.2 By Type, U.S. Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Gene Therapy in CNS Disorder Market Size, 2018-2029
8.4.2 By Type, Europe Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Gene Therapy in CNS Disorder Market Size, 2018-2029
8.5.2 By Type, China Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Gene Therapy in CNS Disorder Market Size, 2018-2029
8.6.2 By Type, Japan Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Gene Therapy in CNS Disorder Market Size, 2018-2029
8.7.2 By Type, South Korea Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Gene Therapy in CNS Disorder Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Gene Therapy in CNS Disorder Market Size, 2018-2029
8.9.2 By Type, India Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Gene Therapy in CNS Disorder Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Voyager Therapeutics
9.1.1 Voyager Therapeutics Company Information, Head Office, Market Area and Industry Position
9.1.2 Voyager Therapeutics Company Profile and Main Business
9.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Models, Specifications and Application
9.1.4 Voyager Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023
9.1.5 Voyager Therapeutics Recent Developments9.2 Spark Therapeutics
9.2.1 Spark Therapeutics Company Information, Head Office, Market Area and Industry Position
9.2.2 Spark Therapeutics Company Profile and Main Business
9.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Models, Specifications and Application
9.2.4 Spark Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023
9.2.5 Spark Therapeutics Recent Developments9.3 Novartis AG
9.3.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
9.3.2 Novartis AG Company Profile and Main Business
9.3.3 Novartis AG Gene Therapy in CNS Disorder Models, Specifications and Application
9.3.4 Novartis AG Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023
9.3.5 Novartis AG Recent Developments9.4 Bluebird Bio Inc.
9.4.1 Bluebird Bio Inc. Company Information, Head Office, Market Area and Industry Position
9.4.2 Bluebird Bio Inc. Company Profile and Main Business
9.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Models, Specifications and Application
9.4.4 Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023
9.4.5 Bluebird Bio Inc. Recent Developments9.5 Biogen
9.5.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.5.2 Biogen Company Profile and Main Business
9.5.3 Biogen Gene Therapy in CNS Disorder Models, Specifications and Application
9.5.4 Biogen Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023
9.5.5 Biogen Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Gene Therapy in CNS Disorder Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Gene Therapy in CNS Disorder Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
It is expected that the Gene Therapy in CNS Disorder Global and China Top Players Market will reach USD XX million by 2029.
According to the Gene Therapy in CNS Disorder Global and China Top Players Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
The Gene Therapy in CNS Disorder Global and China Top Players study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.
